CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
167 hedge funds and large institutions have $752M invested in Clovis Oncology, Inc. in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 72 increasing their positions, 39 reducing their positions, and 41 closing their positions.
Holders
167
Holders Change
-19
Holders Change %
-10.22%
% of All Funds
3.63%
Holding in Top 10
1
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-80%
% of All Funds
0.02%
New
24
Increased
72
Reduced
39
Closed
41
Calls
$69.7M
Puts
$12M
Net Calls
+$57.7M
Net Calls Change
+$48.8M
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$79.3M |
2 |
2
Capital World Investors
Los Angeles,
California
|
$26.2M |
3 |
3
UBS Group
Zurich,
Switzerland
|
$10.6M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$19.9M |
5 |
SC
5
Samlyn Capital
New York
|
$14.2M |